{"url_path":"/sec/avns/8-k/2026-07-15/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1606498/0001606498-26-000093-index.html","accession_number":"0001606498-26-000093","cik":"0001606498","ticker":"AVNS","issuer_name":"AVANOS MEDICAL, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1606498/0001606498-26-000093-index.html","primary_entity_key":"0001606498","primary_entity_name":"AVANOS MEDICAL, INC."},"word_count":276,"has_tables":true,"body_markdown":"avns-20260714\n0001606498falseJuly 14, 202600016064982026-07-142026-07-14\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\nFORM 8-K \n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\nDate of Report: July 14, 2026\n\n(Date of earliest event reported)\n\nAVANOS MEDICAL, INC.\n\n(Exact name of registrant as specified in its charter)\n\nDelaware001-3644046-4987888\n\n(State or other jurisdiction of incorporation)(Commission file number)(I.R.S. Employer Identification No.)\n\n5405 Windward Parkway\n\nSuite 100 South\n\nAlpharetta,Georgia30004\n\n(Address of principal executive offices)(Zip code)\n\nRegistrant’s telephone number, including area code: (844) 428-2667\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):\n\n☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each classTrading SymbolName of exchange on which registered\n\nCommon Stock - $0.01 Par ValueAVNSNew York Stock Exchange\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.\n\nEmerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}